Spinal cord astrocytoma: Response to PCV chemotherapy

Neurology

Volumn 54, Issue 2, 2000, Pages 518-520

  Henson, John W ^a,b,c   Thornton, Allan F ^a,b   Louis, David N ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Brain Tumor Research Center   (United States)

Author keywords

Astrocytoma; Chemotherapy; Spinal neoplasm

Indexed keywords

LOMUSTINE; PROCARBAZINE; VINCRISTINE;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTROCYTOMA; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; HUMAN; MALE; PRIORITY JOURNAL; SPINAL CORD TUMOR; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR LOCALIZATION;

EID: 0034711671     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.54.2.518     Document Type: Article

References (9)

1. Alter M. Statistical aspects of spinal cord tumors. In: Klawans HL, ed. Tumors of the spine and spinal cord: part I. Handbook of clinical neurology. New York: American Elsevier, 1975:1-22.
2. Kopelson G, Linggood RM, Kleinman GM, Doucette J, Wang CC. Management of intramedullary spinal cord tumors. Radiology 1980;135:473-479.
3. Garcia DM. Primary spinal cord tumors treated with surgery and postoperative irradiation. Int J Radiat Oncol Biol Phys 1985;11:1933-1939.
4. Guidetti B, Mercuri S, Vagnozzi R. Long-term results of surgical treatment of 129 intramedullary spinal gliomas. J Neurosurg 1981;54:323-330.
5. Shirato H, Kamada T, Hida K, et al. The role of radiotherapy in the management of spinal cord glioma. Int J Radiat Oncol Biol Phys 1995;33:323-328.
6. Allen JC, Aviner S, Yates AJ, et al. Treatment of high-grade spinal cord astrocytoma with "8-in-1" chemotherapy and radiotherapy: a pilot study of CCG-945. J Neurosurg 1998;88:215-220.
7. Bouffet E, Amat D, Devaux Y, Desuzinges C. Chemotherapy for spinal cord astrocytoma. Med Pediatr Oncol 1997;29:560-562.
8. Linstadt DE, Wara WM, Leibel SA, Gutin PH, Wilson CB, Sheline GE. Postoperative radiotherapy of primary spinal cord tumors. Int J Radiat Oncol Biol Phys 1989;16:1397-1403.
9. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Nat Cancer Inst 1998;90:1473-1479.